Text Size:   A+ A- A   •   Text Only
Find     
Site Image

Evidence Based Reports - Pharmaceutical

These studies are the work of the Health Resources Commission. The commission was eliminated by the 2011 Legislature and replaced by the Pharmacy and Therapeutics Committee.
 

A

Alzheimer Drugs (ALZ)
HRC Report, Update #1 - 10/06

Analgesics/Anesthetics, Topical
OHA PDL Source Document - 4/10

Androgenic Agents
OHA PDL Source Document - 12/09

Angiotensin II Receptor Antagonists (AIIRA)
HRC Report - 3/06  |  Clinician Summary - 3/06

Angiotensin-Converting Enzyme Inhibitors (ACEIs)
HRC Report, Update #2 - 7/05

Antibiotics, Ophthalmic
OHA PDL Source Document - 12/09

Antibiotics, Otic
OHA PDL Source Document - 12/09

Antibiotics, Topical
OHA PDL Source Document - 3/10

Antibiotic-Steroid Combinations, Ophthalmic
OHA PDL Source Document - 3/10

Anticoagulants, Injectable
OHA PDL Source Document - 12/09

Anticonvulsants
OHA PDL Source Document - 12/09

Antidepressants, Second Generation
HRC Draft Report, Update #4 - 1/09  |  Clinician Summary - 6/11

E)
HRC Report - 5/06

Anti-epileptics
Clinician Summary - 6/11

Antifungals, Oral
OHA PDL Source Document - 1/10

Antifungals, Topical
OHA PDL Source Document - 2/10

Antihyperuricemics
OHA PDL Source Document - 5/10

Anti-Inflammatories Ophthalmic
OHA PDL Source Document - 12/09

Antiparasitic Agents, Topical
OHA PDL Source Document - 12/09

Antiparkinson's Agents
OHA PDL Source Document - 3/10

Antiplatelet (AP)
HRC Report, Update #1 - 4/07  |  Clinician Summary - 3/06

Antivirals for HSV
OHA PDL Source Document - 1/10

Antivirals for Influenza
OHA PDL Source Document - 4/10

Asthma, Controller Medications
HRC Report - 9/09  |  Clinician Summary - 12/09

Asthma, Quick Relief Medicines
Clinician Summary - 6/11

Attention Deficit Hyperactivity Disorder (ADHD)
HRC Report - 6/08

Atypical Antipsychotics
HRC Draft Report - 12/10  |  Clinician Summary - 3/11
​​​